In line with our mission to improve quality of life of the patients and save lives, MSS team is supporting ICU staff using Therapeutic Plasma Exchange (TPE) and oXiris on Prismaflex machine from Baxter on COVID-19 positive patients in the Kingdom of Saudi Arabia. The oXiris set device obtained FDA Emergency Use Authorization (EUA) for the treatment of COVID-19 patients with severe symptoms. This device has the potential to clear patient blood from all substances not allowing the immune system to function normally. Our MSS way of confronting COVID-19! Stay safe! For more information, click below:

HTTPS://WWW.BAXTER.COM/BAXTER-NEWSROOM/BAXTER-OBTAINS-US-FDA-EMERGENCY-USE-AUTHORIZATION-OXIRIS-BLOOD-PURIFICATION-FILTER